Marktgröße und Marktanteil von Psoriasis-Therapeutika bis 2025 – 2031
Psoriasis Therapeutics Market Report Analysis
Psoriasis Therapeutics Market
-
CAGR (2025 - 2031)8.4% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Astellas Pharma Inc.
- AstraZeneca plc,
- Boehringer Ingelheim GmbH
- F. Hofffmann-La Roche
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Valeant Pharmaceuticals International, Inc.
- Biocon Limited
- Eli Lilly and Company
Regional Overview
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Market Segmentation
By Arzneimittelklasse
- TNF-Hemmer
- PDE4-Hemmer
- Interleukinblocker
- andere
By Molekültyp
- Biologika
- kleine Moleküle
By Verabreichungsweg
- oral
- parenteral
- topisch
By Geographie
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Get Free Sample For